Ardeparin Subcutaneous and Empagliflozin and Metformin Extended-Release Tablets
Determining the interaction of Ardeparin Subcutaneous and Empagliflozin and Metformin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ardeparin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: Ardeparin (Subcutaneous)
Generic Name: empagliflozin / metformin
Brand name: Synjardy, Synjardy XR
Synonyms: Empagliflozin and metformin, Empagliflozin and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ardeparin Subcutaneous-Empagliflozin and Metformin Tablets
- Ardeparin Subcutaneous-Empliciti
- Ardeparin Subcutaneous-Emsam
- Ardeparin Subcutaneous-Emsam Transdermal
- Ardeparin Subcutaneous-Emtricitabine
- Ardeparin Subcutaneous-Emtricitabine and tenofovir
- Empagliflozin and Metformin Extended-Release Tablets-Aredia
- Empagliflozin and Metformin Extended-Release Tablets-Arestin
- Empagliflozin and Metformin Extended-Release Tablets-Arestin eent
- Empagliflozin and Metformin Extended-Release Tablets-Arestin mucous membrane powder
- Empagliflozin and Metformin Extended-Release Tablets-Arformoterol
- Empagliflozin and Metformin Extended-Release Tablets-Arformoterol inhalation